Joshi explains how medicines first built for diabetes grew into newer GLP-1 therapies used for substantial weight reduction.
Recap by typeshit. Post by Facebook on Facebook.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
Metabolic scientist Ben Bikman shares a short post tagged around GLP-1 drugs, metabolism and low carb diets. Little detail beyond the tags.
No obesity drugs or surgery for kids under 10, the WHO says. Medication and surgery may be considered for some adolescents when lifestyle changes fail.
Loading…